Contemporary Amperex Technology (03750) plans to issue up to 5 billion yuan in technology innovation corporate bonds.

06:33 11/02/2026

Ningde Times (03750) announced that Ningde Times New Energy Technology Co., Ltd. will publicly issue technology innovation corporate bonds (first tranche) for professional investors in 2026, with an issue size not exceeding 5 billion yuan (including 5 billion yuan), and a face interest rate inquiry range of 1.60%-2.20%. The funds raised from this corporate bond issuance, after deducting issuance expenses, will mainly be used for project construction, supplementing working capital, and repaying interest-bearing debts in accordance with legal, regulatory and regulatory requirements.

Contemporary Amperex Technology (03750) announced that Contemporary Amperex Technology Co., Ltd. will publicly issue technology innovation corporate bonds for professional investors in 2026. The total issuance size will not exceed 5 billion yuan, with a coupon rate ranging from 1.60% to 2.20%. The funds raised from this bond issuance will be mainly used for project construction, supplementing operating capital, and repaying interest-bearing debts in accordance with legal, regulatory, and supervisory requirements.

Consumer demand driven, HUITONGDA NET (09878) hard discount supermarket "accelerates upgrade"

WUXI BIO (02269) YINGXI: Shareholders' net profit in 2025 increased by 46.3% year-on-year.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.

Consumer demand driven, HUITONGDA NET (09878) hard discount supermarket "accelerates upgrade"

WUXI BIO (02269) YINGXI: Shareholders' net profit in 2025 increased by 46.3% year-on-year.

ABBISKO-B(02256): The FGFR4 inhibitor erdafitinib has completed the global phase I study extension stage with the first patient dosed in the United States.